TSSP1 - DrugMatrix
DrugMatrix, produced by the U.S. National Toxicology Program, is a molecular toxicology reference database and informatics system. DrugMatrix is populated with the comprehensive results of thousands of highly controlled and standardized toxicological experiments in which rats or primary rat hepatocytes were systematically treated with therapeutic, industrial, ... [more] TOXsIgN May 11, 2020, 12:24 p.m.

TSSP2 - Open TG-GATEs
Open TG-GATEs is a toxicogenomics database open to the public for researchers to utilize research results of TGP and TGP2, and releases the data of 170 compounds stored in TG-GATEs. In Open TG-GATEs, it is possible to search toxicogenomics data by compound name or pathological finding. It is also possible ... [more] TOXsIgN May 11, 2020, 12:24 p.m.

TSSP3 - Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure
Among etiological factors of non-alcoholic fatty liver disease (NAFLD), a worldwide epidemic, environmental contaminants have gained importance. Among them, benzo[a]pyrene (B[a]P), a potent environmental carcinogen, in combination with ethanol, was shown to induce the transition of steatosis toward a steatohepatitis—like state both in vitro and in vivo. However, underlying mechanisms ... [more] / May 4, 2021, 10:45 a.m.

TSSP4 - CMap – carcinogenome project
The Connectivity Map, or CMap, is a resource that uses transcriptional expression data to probe relationships between diseases, cell physiology, and therapeutics. The changes in gene expression, or “signatures,” that arise from a disease, genetic perturbation (knockdown or overexpression of a gene) or treatment with a small molecule are compared ... [more] tdarde Jan. 27, 2022, 9:27 a.m.

TSSP5 - CMap – NLT_CALIB
The Connectivity Map, or CMap, is a resource that uses transcriptional expression data to probe relationships between diseases, cell physiology, and therapeutics. The changes in gene expression, or “signatures,” that arise from a disease, genetic perturbation (knockdown or overexpression of a gene) or treatment with a small molecule are compared ... [more] tdarde Dec. 16, 2022, 1:21 p.m.

There are no superprojects yet.

TSP48920 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to PSI-6130
Public

https://clue.io/data/CMap2020#LINCS2020

[more]
tdarde Feb. 1, 2023, 7:32 a.m.

TSP48921 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to estramustine-phosphate
Public

https://clue.io/data/CMap2020#LINCS2020

[more]
tdarde Feb. 1, 2023, 11:24 a.m.

TSP48922 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to adarotene
Public

https://clue.io/data/CMap2020#LINCS2020

[more]
tdarde Feb. 1, 2023, 11:24 a.m.

TSP48923 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to balaglitazone
Public

https://clue.io/data/CMap2020#LINCS2020

[more]
tdarde Feb. 1, 2023, 11:25 a.m.

TSP48924 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to flutrimazole
Public

https://clue.io/data/CMap2020#LINCS2020

[more]
tdarde Feb. 1, 2023, 11:25 a.m.